7PAW
MALT1 in complex with compound 1
7PAW の概要
エントリーDOI | 10.2210/pdb7paw/pdb |
分子名称 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1, ~{N}1-(3-chloranyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-~{N}4-[2-(trifluoromethyl)pyrimidin-4-yl]cyclohexane-1,4-diamine (3 entities in total) |
機能のキーワード | paracaspase, inhibitor complex, cbm complex, transferase |
由来する生物種 | Homo sapiens (Human) |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 88752.64 |
構造登録者 | |
主引用文献 | Schiesser, S.,Hajek, P.,Pople, H.E.,Kack, H.,Oster, L.,Cox, R.J. Discovery and optimization of cyclohexane-1,4-diamines as allosteric MALT1 inhibitors. Eur.J.Med.Chem., 227:113925-113925, 2021 Cited by PubMed Abstract: Inhibition of mucosa-associated lymphoid tissue lymphoma translocation protein-1 (MALT1) is a promising strategy to modulate NF-κB signaling, with the potential to treat B-cell lymphoma and autoimmune diseases. We describe the discovery and optimization of (1s,4s)-N,N'-diaryl cyclohexane-1,4-diamines, a novel series of allosteric MALT1 inhibitors, resulting in compound 8 with single digit micromolar cell potency. X-ray analysis confirms that this compound binds to an induced allosteric site in MALT1. Compound 8 is highly selective and has an excellent in vivo rat PK profile with low clearance and high oral bioavailability, making it a promising lead for further optimization. PubMed: 34742013DOI: 10.1016/j.ejmech.2021.113925 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.19 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード